Compare HCSG & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCSG | KOD |
|---|---|---|
| Founded | 1976 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Assisted Living Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1994 | 2018 |
| Metric | HCSG | KOD |
|---|---|---|
| Price | $20.19 | $24.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $19.83 | ★ $28.29 |
| AVG Volume (30 Days) | ★ 842.7K | 541.9K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.83 | 32.60 |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $1,837,173,000.00 | N/A |
| Revenue This Year | $7.39 | N/A |
| Revenue Next Year | $5.22 | N/A |
| P/E Ratio | $25.51 | ★ N/A |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $9.13 | $1.92 |
| 52 Week High | $22.98 | $31.18 |
| Indicator | HCSG | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 46.58 |
| Support Level | $18.28 | $23.92 |
| Resistance Level | $22.69 | $26.21 |
| Average True Range (ATR) | 0.64 | 1.95 |
| MACD | -0.15 | -0.11 |
| Stochastic Oscillator | 15.59 | 36.16 |
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.